Creo Medical Group PLC Share Price
Equities
CREO
GB00BZ1BLL44
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.25 GBX | 0.00% | +4.32% | -21.20% |
04-24 | ActiveOps sales up; Sancus turnover jumps | AN |
03-01 | EARNINGS AND TRADING: Dar Global celebrates "outstanding" year | AN |
Sales 2023 * | 32.03M 40.02M 3.2B | Sales 2024 * | 40.6M 50.72M 4.06B | Capitalization | 126M 158M 12.63B |
---|---|---|---|---|---|
Net income 2023 * | -18M -22.49M -1.8B | Net income 2024 * | -11M -13.74M -1.1B | EV / Sales 2023 * | 3.26 x |
Net cash position 2023 * | 22.05M 27.54M 2.2B | Net cash position 2024 * | 15.67K 19.57K 1.57M | EV / Sales 2024 * | 3.11 x |
P/E ratio 2023 * |
-6.25
x | P/E ratio 2024 * |
-11.2
x | Employees | 279 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 79.37% |
1 week | +4.32% | ||
Current month | +5.84% | ||
1 month | +2.11% | ||
3 months | -12.12% | ||
6 months | +9.85% | ||
Current year | -21.20% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Craig Gulliford
CEO | Chief Executive Officer | - | 31/12/11 |
President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 30/06/16 |
John Bradshaw
BRD | Director/Board Member | 60 | - |
Craig Gulliford
CEO | Chief Executive Officer | - | 31/12/11 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 36.25 | 0.00% | 299,147 |
25/04/24 | 36.25 | +3.28% | 695,375 |
24/04/24 | 35.1 | +1.01% | 380,957 |
23/04/24 | 34.75 | 0.00% | 45,800 |
22/04/24 | 34.75 | 0.00% | 85,305 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.20% | 157M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.01B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- CREO Stock